The IPOX® Update 11/20/23
IPOX® CEO Josef Schuster analyzes the volatile IPO market, noting a 2023 rebound with 76 IPOs raising $15 billion. Private equity firms are reacquiring companies post-IPO slump, with notable buybacks in several sectors. Turkey's IPO market is surging, expecting 100 companies to list in 2024. Carmot Therapeutics, focusing on obesity and diabetes drugs, announced plans for an IPO to raise up to $100 million.
Read edition